If Sustainability Is A Priority For Biopharma, Why Is Progress So Slow?

By Ryan Walker, Sustainability Program Leader

Sustainability has become a staple of corporate messaging, especially in biopharma, where environmental responsibility is increasingly tied to long‑term resilience and stakeholder trust. Yet the latest 2025 Global Biopharma Index exposes a disconnect between intention and progress. Organizations widely acknowledge sustainability as essential, but many are struggling to translate ambition into measurable action. Competing priorities, limited resources, and pressure to deliver near‑term results are slowing momentum at a time when expectations are rapidly rising.

Explore why the industry’s sustainability goals are stalling and what barriers biopharma leaders must overcome to close the gap between vision and reality. See what’s driving this paradox and where forward‑thinking organizations are finding traction.